Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
S-methylmethionine, historically known as vitamin U, is a small molecule derivative of the amino acid methionine that is naturally synthesized in various plants, particularly cruciferous vegetables like cabbage. Although not a true vitamin, it was named for its anti-ulcerogenic properties in the gastrointestinal tract. The compound exerts therapeutic effects by promoting dermal fibroblast migration and growth through the activation of the ERK1/2 signaling pathway. Additionally, it acts as a potent antioxidant, protecting tissues from oxidative stress and lipid peroxidation, as demonstrated in experimental models of epilepsy and brain damage. It is primarily available as a research compound and dietary supplement rather than an approved pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on s-methylmethionine.